Recent Finacing
Recent Raise
HBC Immunology discovers and develops peptide therapeutics (FT-002, FT-005) that modulate iron metabolism to normalize tumor microenvironments, advancing preclinical xenograft and in vitro programs in prostate, breast, and ovarian cancer.
Focus Areas
Valuation as of 08/17/2023
Total Raised
Funding round